MAO-A/5-HT2AR-IN-1

• CAT Number: I042741
• CAS Number: 2769156-00-3
• Molecular Formula: C30H28FN3O2
• Molecular Weight: 481.56
• Purity: ≥95%
• Synonyms: 11-[4-[4-(2-fluorophenyl)piperazin-1-yl]butoxy]-16-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one
• InChI: InChI=1S/C30H28FN3O2/c31-26-9-3-4-10-27(26)34-16-14-33(15-17-34)13-5-6-18-36-22-19-21-11-12-32-29-23-7-1-2-8-24(23)30(35)25(20-22)28(21)29/h1-4,7-12,19-20H,5-6,13-18H2
• InChIKey: GWRCLKVKZRBZJA-UHFFFAOYSA-N
• SMILES: C1CN(CCN1CCCCOC2=CC3=C4C(=C2)C=CN=C4C5=CC=CC=C5C3=O)C6=CC=CC=C6F

MAO-A/5-HT2AR-IN-1（Cat No.:I042741）is a dual-target inhibitor designed to modulate the activity of two key receptors: Monoamine Oxidase A (MAO-A) and the 5-Hydroxytryptamine 2A Receptor (5-HT2AR). MAO-A is involved in the breakdown of neurotransmitters such as serotonin, dopamine, and norepinephrine, while 5-HT2AR plays a role in serotonin signaling. By inhibiting both targets, MAO-A/5-HT2AR-IN-1 may have potential therapeutic applications in neuropsychiatric disorders, including depression, anxiety, and schizophrenia. The compound is used in research to explore the interplay between serotonin regulation and MAO-A activity in these conditions.